The gut microbiota-tryptophan metabolism-immune axis in inflammatory bowel disease: Mechanisms and therapeutic prospects. [PDF]
Hum Vaccin ImmunotherWang T, Wang X, Yuan W.
europepmc +1 more source
Targeting tryptophan metabolism in breast cancer immunotherapy: Recent advances and future prospects. [PDF]
Transl OncolLi G, Zhou H, Shen X, Ying P, Lu H.
europepmc +1 more source
Combine immune checkpoint indoleamine 2,3-dioxygenase 1 knockdown with ferroptosis inducer Erastin/RSL3 accelerates colorectal cancer cell ferroptosis. [PDF]
CytojournalLi F +5 more
europepmc +1 more source
Bicaudal‑C1 in Cancer: Molecular Mechanisms and Therapeutic Strategies Integrating Chinese and Western Medicine. [PDF]
Drug Des Devel TherJiang X +9 more
europepmc +1 more source
A Reproducible Hierarchical Virtual Screening Framework Integrating Scaffold-Aware Machine Learning, Ensemble Docking, and Molecular Dynamics: Application to IDO1. [PDF]
J Chem Inf ModelTomarchio EG, Buccheri R, Rescifina A.
europepmc +1 more source
IDO1 Silencing Enhances Cisplatin Sensitivity in Gastric Cancer Cells via Modulation of Apoptosis and Oxidative Stress. [PDF]
Curr Issues Mol BiolTaghavi Pourianazar N +2 more
europepmc +1 more source
<i>CDKN2A</i> mRNA Over-expression Is Associated With CD8+ T Cell Exclusion and IDO1-Mediated Adaptive Immune Resistance in Gastric Adenocarcinoma. [PDF]
Cancer Diagn PrognLehrer S, Rheinstein P.
europepmc +1 more source
Differentiation therapy targeting indoleamine 2,3-dioxygenase 1 in glioblastoma cells <i>in vitro</i>. [PDF]
Mol Clin OncolNishide K +5 more
europepmc +1 more source
Tryptophan metabolism in tumor immune escape: mechanisms, cellular crosstalk, and therapeutic opportunities. [PDF]
Front ImmunolChen J, Wang X, Gong M, Wang Y, Yu T.
europepmc +1 more source